NCT02992977 Safety and Tolerability Study of AutoSynVax™ Vaccine in Subjects With Advanced Cancer Status TERMINATED Phase PHASE1
NCT02992171 Primary Palliative Care for Patients With Advanced Hematologic Malignancies Status COMPLETED Phase NA
NCT02980289 DAnish Nausea Study In Advanced Cancer-Epidemiology: A Danish Multicenter Trial to Investigate the Prevalence and Treatment of Nausea and/or Vomiting in Patients With Advanced Cancer. Status COMPLETED Phase N/A
NCT02957565 Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care Visit Status COMPLETED Phase NA
NCT02944864 A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics Status TERMINATED Phase PHASE1
NCT02930876 Feasibility of Home vs. Hospital Based Resistance Training for Advanced Cancer Patients Status COMPLETED Phase PHASE2
NCT02919696 A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic Cancers Status COMPLETED Phase PHASE1
NCT02915172 Lenvatinib and Capecitabine in Patients With Advanced Malignancies Status WITHDRAWN Phase PHASE1
NCT02889445 A Phase I Trial of DM-CHOC-PEN in Adolescent and Young Adult (AYA) Subjects With Advanced Cancers Status NO_LONGER_AVAILABLE Phase N/A
NCT02860780 A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT02857270 A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer Status COMPLETED Phase PHASE1
NCT02841124 Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies. Status COMPLETED Phase NA
NCT02825563 A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients Status COMPLETED Phase PHASE1
NCT02805660 Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC Status TERMINATED Phase PHASE1/PHASE2
NCT02801097 RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD) Status TERMINATED Phase PHASE1
NCT02797795 A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers Status COMPLETED Phase PHASE1